Paxlovid Prescribing – Navigating Uncertainties

Gain valuable insights and practical knowledge on how to manage challenges and uncertainties when prescribing medication.


This product is accessible only by members. log in or become a member



This course contains recordings of two live webinars, held on December 21, 2022 and February 6, 2023

The first webinar provided an overview of the current evidence available December 2022 for nirmatrelvir/ritonavir (Paxlovid) in the treatment of COVID-19 infection. It explained the process for prescribing, discussed the assessment of the risk of progression to severe illness, and the management of drug interactions.

The second webinar was a check-in on 2 months of pharmacists prescribing in Ontario. It contains statistics, up-to-date evidence, and further discussion on the nuances of prescribing this medication. The information was delivered by a panel of pharmacists.

This webinar is supported by an education grant from Pfizer Canada ULC